Localization and Molecular Targets
Toll-like receptors are strategically positioned on cells that are the first to encounter potential infectious agents. They are particularly abundant on patrolling leukocytes. In addition, these receptors are widely expressed in barrier tissues: the gastrointestinal epithelium, vascular endothelium, skin keratinocytes, and microglial cells.
The primary function of TLRs is to detect pathogen-associated molecular patterns (PAMPs). These are evolutionarily conserved microbial structures that are vital for pathogen survival but completely absent in the human body. Key types of PAMPs include:
- Lipopolysaccharides (LPS), which form the basis of the outer membrane in Gram-negative bacteria.
- Lipoteichoic acids, characteristic of Gram-positive microorganisms.
- Peptidoglycans of the bacterial cell wall.
- Specific nucleic acids: bacterial DNA and viral RNA.
Signal Transduction and the Role of CD14 Glycoprotein
Precise and efficient recognition of Gram-negative bacteria requires the participation of the specific CD14 glycoprotein. Cells expressing CD14 (monocytes, tissue macrophages, dendritic cells, and activated granulocytes) ensure exceptionally high affinity in the complex formed between bacterial LPS and the Toll-like receptor.
Binding of TLRs to PAMPs initiates a powerful intracellular response. With the mandatory involvement of adapter proteins, a signaling cascade is triggered, leading to the following events:
- Activation of the critical nuclear transcription factor NF-$\kappa$B.
- The activated factor translocates to the nucleus and initiates the expression of genes encoding pro-inflammatory cytokines.
Downstream effects of this cascade drive a full-scale immune response. Phagocytic cells are activated, T and B lymphocytes are stimulated, and the synthesis of protective immunoglobulins (Igs) is significantly enhanced.
Receptor Specificity to Pathogens
Innate immunity differentiates threats due to strict receptor specificity. Depending on the invading infectious agent, various TLR types are expressed on the surface of immune cells, allowing the selection of the most appropriate defense strategy.
- Gram-positive bacteria: Recognized predominantly by TLR2, which responds to their surface structures.
- Gram-negative bacteria: Identified via TLR4, tuned to detect lipopolysaccharides.
- Viral infections: Trigger the expression of a broad spectrum of receptors, including TLR1, TLR2, TLR3, TLR7, TLR8, and TLR9, which respond to viral components.
TLR System Pathology and Immunodeficiencies
Because Toll-like receptors are a foundational element of innate immunity, any defects in their function inevitably lead to increased host susceptibility to infectious diseases.
Two main causes of such impairments exist:
- Direct mutations in genes encoding the TLR receptors themselves.
- Congenital defects in intracellular signaling pathways transmitting signals from the receptor to the nucleus.
In clinical practice, mutations in the TLR4 gene—specifically the Asp299Gly and Thr399Ile genetic variants—are of particular significance. The pathogenesis of these mutations involves an insufficient, attenuated response to bacterial lipopolysaccharide. Consequently, patients face a significantly higher frequency of infections caused by Gram-negative microbes, as well as an elevated risk of severe bronchiolitis.